$283.00
0.27% yesterday
NYSE, May 09, 10:00 pm CET
ISIN
US03073E1055
Symbol
COR

Cencora Stock price

$283.00
+9.11 3.33% 1M
+33.91 13.61% 6M
+58.32 25.96% YTD
+58.91 26.29% 1Y
+125.68 79.89% 3Y
+192.36 212.22% 5Y
+168.09 146.28% 10Y
NYSE, Closing price Fri, May 09 2025
-0.77 0.27%
ISIN
US03073E1055
Symbol
COR
Sector

Key metrics

Market capitalization $54.85b
Enterprise Value $60.76b
P/E (TTM) P/E ratio 32.84
EV/FCF (TTM) EV/FCF 17.00
EV/Sales (TTM) EV/Sales 0.20
P/S ratio (TTM) P/S ratio 0.18
P/B ratio (TTM) P/B ratio 54.15
Dividend yield 0.72%
Last dividend (FY24) $2.04
Revenue growth (TTM) Revenue growth 12.18%
Revenue (TTM) Revenue $310.23b
EBIT (operating result TTM) EBIT $3.18b
Free Cash Flow (TTM) Free Cash Flow $3.58b
Cash position $2.11b
EPS (TTM) EPS $8.62
P/E forward 21.38
P/S forward 0.17
EV/Sales forward 0.19
Short interest 5.97%
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Cencora forecast:

11x Buy
58%
8x Hold
42%

Analyst Opinions

19 Analysts have issued a Cencora forecast:

Buy
58%
Hold
42%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
310,232 310,232
12% 12%
100%
- Direct Costs 301,103 301,103
12% 12%
97%
9,129 9,129
12% 12%
3%
- Selling and Administrative Expenses 4,848 4,848
11% 11%
2%
- Research and Development Expense - -
-
-
4,282 4,282
12% 12%
1%
- Depreciation and Amortization 1,098 1,098
1% 1%
0%
EBIT (Operating Income) EBIT 3,184 3,184
18% 18%
1%
Net Profit 1,693 1,693
9% 9%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cencora Stock News

Neutral
Seeking Alpha
3 days ago
Cencora, Inc. (NYSE:COR ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President, Head of Investor Relations & Treasury Bob Mauch - President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Capital Lisa Gil...
Positive
Reuters
3 days ago
U.S. drug distributor Cencora raised its annual profit forecast on Wednesday, driven by robust demand for costly specialty medicines and weight-loss drugs.
Neutral
Business Wire
3 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year to $75.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.68 for the second quarter of fiscal 2025 compared to $2.09 in the prior year second qu...
More Cencora News

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Robert Mauch
Employees 46,000
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today